Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

EREG therapy may help treat hair loss by promoting hair growth.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

DM and AA may share a common cause.

Anti-Ku antibodies are linked to unique symptoms and may involve autophagy issues.

Retinol may affect immune responses in people with frequent skin boils.

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Some drugs used to treat inflammation may cause hair loss.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Activating autophagy might reverse skin fibrosis.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.